Document Detail


Ten year survival of a patient with advanced pulmonary hypertension and mixed connective tissue disease treated with immunosuppressive therapy.
MedLine Citation:
PMID:  1491407     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pulmonary hypertension is the most frequent cause of death in patients with mixed connective tissue disease. The pulmonary hypertension is progressive and difficult to treat effectively. These patients experience considerable morbidity secondary to diminished cardiac function. We describe a case in which sequential administration of cyclophosphamide and cyclosporine A favorably altered the clinical and hemodynamic course of this serious complication.
Authors:
M Dahl; A Chalmers; J Wade; D Calverley; B Munt
Related Documents :
16027687 - Portopulmonary hypertension in pediatric patients.
6120577 - Hypertension management and patient compliance at a soweto polyclinic.
21180597 - Functional dyspepsia.
3618497 - Variable responses of mitral valve motion and flow in systemic hypertension and in idio...
24289617 - Clinicopathologic and demographic evaluation of triple- negative breast cancer patients...
8183467 - Wilson's disease: mri with clinical correlation.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of rheumatology     Volume:  19     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  1992 Nov 
Date Detail:
Created Date:  1993-03-04     Completed Date:  1993-03-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  1807-9     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of British Columbia, Vancouver, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cyclophosphamide / therapeutic use
Cyclosporine / therapeutic use
Female
Hemodynamics / drug effects
Humans
Hypertension, Pulmonary / complications*,  drug therapy*
Immunosuppressive Agents / therapeutic use*
Mixed Connective Tissue Disease / complications*,  drug therapy*
Chemical
Reg. No./Substance:
0/Immunosuppressive Agents; 50-18-0/Cyclophosphamide; 59865-13-3/Cyclosporine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bilateral renal artery occlusion in a patient with primary antiphospholipid antibody syndrome: throm...
Next Document:  Human immunodeficiency virus (HIV) and HIV infected cells in saliva and salivary glands of a patient...